- Home
- KFFB vs ENLV Comparison
KFFB vs ENLV Comparison
Compare KFFB & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFFB
- ENLV
- Stock Information
- Founded
- KFFB 2005
- ENLV 2005
- Country
- KFFB United States
- ENLV Israel
- Employees
- KFFB N/A
- ENLV N/A
- Industry
- KFFB Savings Institutions
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- KFFB Finance
- ENLV Health Care
- Exchange
- KFFB Nasdaq
- ENLV Nasdaq
- Market Cap
- KFFB 24.1M
- ENLV 25.9M
- IPO Year
- KFFB 2005
- ENLV 1995
- Fundamental
- Price
- KFFB $2.66
- ENLV $1.20
- Analyst Decision
- KFFB
- ENLV Strong Buy
- Analyst Count
- KFFB 0
- ENLV 2
- Target Price
- KFFB N/A
- ENLV $9.50
- AVG Volume (30 Days)
- KFFB 7.9K
- ENLV 462.9K
- Earning Date
- KFFB 02-10-2025
- ENLV 11-29-2024
- Dividend Yield
- KFFB N/A
- ENLV N/A
- EPS Growth
- KFFB N/A
- ENLV N/A
- EPS
- KFFB N/A
- ENLV N/A
- Revenue
- KFFB $7,475,000.00
- ENLV N/A
- Revenue This Year
- KFFB N/A
- ENLV N/A
- Revenue Next Year
- KFFB N/A
- ENLV N/A
- P/E Ratio
- KFFB N/A
- ENLV N/A
- Revenue Growth
- KFFB N/A
- ENLV N/A
- 52 Week Low
- KFFB $2.50
- ENLV $0.81
- 52 Week High
- KFFB $4.83
- ENLV $4.59
- Technical
- Relative Strength Index (RSI)
- KFFB 45.83
- ENLV 50.34
- Support Level
- KFFB $2.75
- ENLV $1.13
- Resistance Level
- KFFB $3.00
- ENLV $1.24
- Average True Range (ATR)
- KFFB 0.14
- ENLV 0.10
- MACD
- KFFB 0.01
- ENLV 0.01
- Stochastic Oscillator
- KFFB 19.05
- ENLV 58.10
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.